Call for consensus in Chlamydia trachomatis nomenclature: moving from biovars, serovars, and serotypes to genovariants and genotypes

Affiliations

• ¹ Department of Infectious Diseases, Center for Sexual Health, Public Health Service, Amsterdam, the Netherlands; Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Academic Medical Centre, Amsterdam, the Netherlands.
• ² Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Academic Medical Centre, Amsterdam, the Netherlands; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Academic Medical Centre, Amsterdam, the Netherlands.
• ³ Center for Immunobiology and Vaccine Development, University of California San Francisco, Benioff Children's Hospital, Oakland Research Institute, Oakland, CA, USA.
• ⁴ Department of Microbial Pathogenesis, School of Dentistry, University of Maryland, Baltimore, MD, USA.
• ⁵ Department of Pathobiology, Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
• ⁶ Institute of Microbiology of the University of Lausanne and University Hospital Center, Lausanne, Switzerland; ICSP Subcommittee on the Taxonomy of Chlamydiae, Lausanne, Switzerland. Electronic address: gilbert.greub@chuv.ch.
• ⁷ Department of Genetics and Cell Biology, Institute for Public Health Genomics, Research School GROW (School for Oncology & Developmental Biology), Faculty of Health, Medicine & Life Sciences, University of Maastricht, Maastricht, the Netherlands; Dutch Chlamydia Trachomatis Reference Laboratory, Department of Medical Microbiology & Infection Control, VU University Medical Centre, Amsterdam, the Netherlands.